SLD 0.42 ▲0.00% MBG 0.21 ▲0.00% FDC 3.93 ▼-0.76% LF1 1.87 ▼-2.12% LGF 2.38 ▲0.86% DN1 98.00 ▼-0.17% WMX 1.58 ▼-2.46% RG8 2.52 ▲0.40% CTS 0.89 ▲2.89% TET 0.42 ▲1.20% MRE 1.68 ▲0.00% BST 0.27 ▲3.85% EFR 0.01 ▲0.00% RIV 1.20 ▼-0.42% KIT 1.80 ▲0.56% EMUCA 0.89 RF1 3.38 ▲0.00% AIX 9.00 ▲0.22% SLD 0.42 ▲0.00% MBG 0.21 ▲0.00% FDC 3.93 ▼-0.76% LF1 1.87 ▼-2.12% LGF 2.38 ▲0.86% DN1 98.00 ▼-0.17% WMX 1.58 ▼-2.46% RG8 2.52 ▲0.40% CTS 0.89 ▲2.89% TET 0.42 ▲1.20% MRE 1.68 ▲0.00% BST 0.27 ▲3.85% EFR 0.01 ▲0.00% RIV 1.20 ▼-0.42% KIT 1.80 ▲0.56% EMUCA 0.89 RF1 3.38 ▲0.00% AIX 9.00 ▲0.22%

CP8 Canadian Phosphate Limited

Basic Materials · Agricultural Inputs · website
$0.14
52wk 0.04 – 0.20
Overall
51.1
Value
60.6
Growth
3.5
Health
100.0
Quality
0.0
Momentum
87.7
Dividend
—
Price
About Canadian Phosphate Limited

Canadian Phosphate Limited supplies regenerative phosphate and organic fertilizers products in Australia and North America. The company holds interests in two rock phosphate mining projects, comprising the Wapiti project comprising an area of approximately 78 km²; and Fernie projects that covers an area of approximately 108 km² in British Columbia, Canada. It also offers fused calcium magnesium silica phosphate products. The company was formerly known as Fertoz Limited and changed its name to Canadian Phosphate Limited in February 2025. Canadian Phosphate Limited was incorporated in 2010 and is based in Perth, Australia.

Price analytics

Returns

1 day 0.0%
1 week -9.7%
1 month -9.7%
3 months 40.0%
6 months 109.0%
1 year 169.2%
3 years 91.8%

Risk

Volatility (1y ann.) 109.1%
Beta vs ASX 200 0.52
Sharpe (1y) 1.41
VaR 95% (1-day) -10.0%
Max drawdown (1y) -48.7%
Off 1-year high -28.2%

Technicals

RSI(14) 44
vs 50DMA 5.8%
vs 200DMA 23.5%
Trend Golden cross
Fundamental trends
Financial statements
Loading…
Scoring breakdown (2 Oct 2026)
Value 60.6
Trailing P/E
—
Forward P/E
—
PEG ratio
—
EV / EBITDA
100
Price / Book
56
Price / Sales
0
Growth 3.5
Revenue growth (1y)
7
Revenue CAGR (3y)
0
EPS growth (1y)
—
EPS CAGR (3y)
—
Financial Health 100.0
Net debt / EBITDA
—
Interest coverage (EBIT/interest)
—
Current ratio
100
Debt / Equity
100
Quality (Profitability & Cash Flow) 0.0
Return on equity
0
Return on assets
0
Operating margin
0
Net margin
0
Cash conversion (OCF / net income)
—
Dividend / Income —
No meaningful dividend — pillar excluded from the overall score.
Momentum 87.7
6-month return vs ASX 200
100
Price vs 200-day average
100
Price vs 50-day average
79
Position in 52-week range
62

Hover a row's info icon for the exact rule. Bounds and weights are configurable in the Django admin (Scoring configuration).

Score history
Key metrics
Market cap
$55.23M
P/E (trailing)
—
P/E (forward)
—
EPS (trailing)
-0.01
Dividend yield
—
Payout ratio
0.0%
Beta
1.51
EV / EBITDA
-32.28
Price / Book
4.00
ROE
-20.9%
Operating margin
-122.6%
Net margin
-136.9%
Total cash
$6.57M
Total debt
$79,984
Current ratio
21.61
Debt / Equity
0.01
Free cash flow
$536,905
Avg volume
66,449
Latest annual results (FY ending 31 Dec 2025)
  • Revenue$2.31M
  • Gross profit$1.17M
  • Operating income-$1.62M
  • Net income-$2.21M
  • Diluted EPS-0.01
  • Free cash flow-$1.02M
  • Net debt-$2.00M
Sector peers (Basic Materials)
TickerMkt cap P/EScore
BHP $311.13B 22.0 68.1
RIO $268.04B 15.5 58.1
NEM $174.41B 14.5 82.2
FMG $49.85B 12.1 60.7
NST $34.22B 20.7 76.0
EVN $26.76B 17.9 79.4
S32 $22.08B 14.5 67.1
JHX $20.94B 112.7 45.6